Sigachi Industries enterprise value

Share price at each year-end

Tap a line for its trend	Currentlast 12M	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus


1,014	—	—	—	—	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
20.9	20.9	17.3	17.4	13.8
7.2	7.2	12.2	11.4	0.0
136	136	142	143	40.5
1,136	—	—	—	—
115	115	125	126	26.7
₹29.73	—	—	—	—

664	664	755	584	309
20.4%	20.4%	18.8%	24.5%	13.1%
0.12×	—	—	—	—

2.41×	—	—	—	—
24.61×	—	—	—	—
39.32×	—	—	—	—
471	478	488	399	302
46.2	53.7	100.0	76.7	58.7
28.9	36.2	84.2	65.9	52.1
—	4.3	26.9	12.9	29.0
−36.9	−36.9	−16.4	−72.3	−71.7
—	−37.6	−19.3	−73.7	−72.6
—	41.2	43.3	85.2	101

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

SIGACHI₹26.54

Sigachi Industries Limited

· Pharma & Health

₹ CrorePeersLINCOLN THEMISMED BAJAJHCARE AMRUTANJANJAGSNPHARM WANBURY NGLFINEMcap ₹1,014 Cr

HighlightsEnterprise Value Multiples Per ShareAnnuals · FY-end closes

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Current/LTM TTM · last close
Market Capitalization	—	—	—	—	1,014.1
- Cash, Equiv & ST Investments	13.8	17.4	17.3	20.9	20.9
+ Minority Interest	0.0	11.4	12.2	7.2	7.2
+ Total Debt	40.5	143.1	142.2	135.6	135.6
Enterprise Value	—	—	—	—	1,136.0
Net Debt (memo)	26.7	125.6	124.9	114.7	114.7
EV per Share	—	—	—	—	29.73

Total Capital	308.9	584.1	755.2	664.4	664.4
Total Debt/Total Capital	13.11	24.49	18.82	20.40	20.40
Total Debt/EV	—	—	—	—	0.12

EV/Sales	—	—	—	—	2.41
EV/EBITDA	—	—	—	—	24.61
EV/EBIT	—	—	—	—	39.32
Reference Items — Trailing FY Values
Sales	302.0	399.0	488.2	477.8	470.9
EBITDA	58.7	76.7	100.0	53.7	46.2
EBIT	52.1	65.9	84.2	36.2	28.9
Operating Cash Flow	29.0	12.9	26.9	4.3	—
Free Cash Flow	-71.7	-72.3	-16.4	-36.9	-36.9
FCFF (free cash flow to the firm)	-72.6	-73.7	-19.3	-37.6	—
Capital Expenditure	100.7	85.2	43.3	41.2	—

Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.